antilichaam
drug of geneesmiddel
|
|
monoklonaal antilichaam (substantie)
monoklonaal antilichaam
monoklonale antistof
monoklonale immunoglobuline
Monoclonal antibody
Monoclonal immunoglobulin
Monoclonal protein
Id
49616005
Status
Primitive
|
Abciximab
adalimumab
Aducanumab
alemtuzumab
Alirocumab
Alpha heavy chain
Amivantamab
Ansuvimab
antigeen MIB-1
Arcitumomab
atezolizumab
Atoltivimab
Avelumab
Basiliximab
bebtelovimab
belantamab mafodotin
belimumab
Benralizumab
Besilesomab
bevacizumab
Bimekizumab
Bispecific monoclonal antibody
10
Brentuximab vedotin
Brodalumab
Brolucizumab
canakinumab
Caplacizumab
capromabpendetide
casirivimab
Cemiplimab
certolizumabpegol
cetuximab
Cilgavimab
Daclizumab
Daratumumab
Delta heavy chain
denosumab
Dinutuximab
Dinutuximab beta
Dostarlimab
Dupilumab
Durvalumab
eculizumab
Efalizumab
Efgartigimod alfa
Elotuzumab
Emapalumab
Enfortumab vedotin
Epsilon heavy chain
Eptinezumab
Erenumab
Etesevimab
Evinacumab
Evolocumab
Fremanezumab
Galcanezumab
Gamma heavy chain
Gemtuzumab ozogamicin
golimumab
HML-1
Ibalizumab
ibritumomabtiuxetan
Idarucizumab
imdevimab
Inebilizumab
infliximab
Inolimomab
Inotuzumab ozogamicin
ipilimumab
Isatuximab
Itolizumab
ixekizumab
Lanadelumab
Loncastuximab tesirine
Maftivimab
Margetuximab
mepolizumab
Mogamulizumab
Monoclonal antibody to Orthopneumovirus hominis
Monoclonal IgA
Monoclonal IgD
Monoclonal IgE
Monoclonal IgG
23
Monoclonal IgM
Moxetumomab pasudotox
Mu heavy chain
Muromonab-CD3
Naptumomab
natalizumab
Naxitamab
Necitumumab
Nimotuzumab
nivolumab
Obiltoxaximab
obinutuzumab
ocrelizumab
Odesivimab
ofatumumab
Olaratumab
Omalizumab
Oregovomab
Palivizumab
panitumumab
Paraprotein
2
pembrolizumab
pertuzumab
Polatuzumab vedotin
ramucirumab
ranibizumab
Ravulizumab
Raxibacumab
Reslizumab
rituximab
Romosozumab
Sacituzumab
Sacituzumab govitecan
sarilumab
Satralizumab
secukinumab
Siltuximab
sotrovimab
Spesolimab
Tafasitamab
Talquetamab
Teprotumumab
Tixagevimab
tocilizumab
Tositumomab
Tralokinumab
trastuzumab
Trastuzumab deruxtecan
trastuzumab-emtansine
Ublituximab
ustekinumab
vedolizumab
Zanolimumab
